Treatment of angiostrongyliasis.
Sawanyawisuth K, Sawanyawisuth K.
Trans R Soc Trop Med Hyg. 2008 Oct;102(10):990-6. doi: 10.1016/j.trstmh.2008.04.021. Epub 2008 May 27.
Angiostrongyliasis in the Americas.
Dorta-Contreras AJ, Magraner-Tarrau ME, Sánchez-Zulueta E.
Emerg Infect Dis. 2009 Jun;15(6):991. doi: 10.3201/eid1506.071708.
Pathology in Practice.
Warshaw M, Crossland NA, DiGeronimo PM, Jarvi SI, Pirie GJ Jr, Evans DE.
J Am Vet Med Assoc. 2018 Mar 1;252(5):545-548. doi: 10.2460/javma.252.5.545.
Angiostrongyliasis cantonensis.
Scrimgeour EM, Burke WJ.
Aust N Z J Med. 1979 Feb;9(1):75-7. doi: 10.1111/j.1445-5994.1979.tb04119.x.
[Angiostrongyliasis].
Takeuchi T.
Ryoikibetsu Shokogun Shirizu. 1999;(24 Pt 2):474-6.
Angiostrongylus cantonensis and neuroangiostrongyliasis (rat lungworm disease): 2020.
Jarvi S, Prociv P.
Parasitology. 2021 Feb;148(2):129-132. doi: 10.1017/S003118202000236X. Epub 2020 Dec 14.
Central nervous system manifestations of Angiostrongylus cantonensis infection.
Martins YC, Tanowitz HB, Kazacos KR.
Acta Trop. 2015 Jan;141(Pt A):46-53. doi: 10.1016/j.actatropica.2014.10.002. Epub 2014 Oct 13.
Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection: Systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis.
Cavaliere E, Nosadini M, Pelizza MF, Ventura G, Toldo I, Sartori S.
J Neuroimmunol. 2019 Jul 15;332:1-7. doi: 10.1016/j.jneuroim.2019.03.011. Epub 2019 Mar 19.
Angiostrongyliasis cantonensis (eosinophilic meningitis, Alicata's disease).
Jindrak K.
Contemp Neurol Ser. 1975;12:133-64.
[Advances in pathogenic mechanisms of Angiostrongylus cantonensis infection].
Yao L, Xi S, Zhong-Dao W.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019 Mar 16;31(1):98-104. doi: 10.16250/j.32.1374.2018305.
